Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Return on Assets (2020 - 2025)

Arcutis Biotherapeutics (ARQT) has 6 years of Return on Assets data on record, last reported at 0.27% in Q2 2025.

  • For Q2 2025, Return on Assets changed N/A year-over-year to 0.27%; the TTM value through Jun 2025 reached 0.27%, changed N/A, while the annual FY2024 figure was 0.41%, 26.0% up from the prior year.
  • Return on Assets reached 0.27% in Q2 2025 per ARQT's latest filing, up from 0.37% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.27% in Q2 2025 and bottomed at 0.95% in Q2 2023.
  • Average Return on Assets over 5 years is 0.62%, with a median of 0.63% recorded in 2022.
  • Peak YoY movement for Return on Assets: decreased -19bps in 2023, then surged 47bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.52% in 2021, then dropped by -26bps to 0.66% in 2022, then decreased by -26bps to 0.83% in 2023, then soared by 57bps to 0.36% in 2024, then increased by 25bps to 0.27% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.27% in Q2 2025, 0.37% in Q1 2025, and 0.36% in Q4 2024.